Baxter International Inc (BAX)

BAX on New York Consolidated

38.59USD
27 Aug 2015
Change (% chg)

$0.92 (+2.44%)
Prev Close
$37.67
Open
$37.97
Day's High
$38.77
Day's Low
$37.74
Volume
9,204,573
Avg. Vol
11,040,103
52-wk High
$43.44
52-wk Low
$34.50

BAX

Chart for BAX

About

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $20,550.45
Shares Outstanding(Mil.): 545.54
Dividend: 0.12
Yield (%): 1.22

Financials

  BAX Industry Sector
P/E (TTM): 11.95 38.11 34.00
EPS (TTM): 3.15 -- --
ROI: 7.94 11.88 14.57
ROE: 20.74 13.92 15.46
Search Stocks

Loeb asks for board seats at Baxter, discloses new stake

BOSTON - Billionaire investor Daniel Loeb on Wednesday asked for two board seats at Baxter International after publicly unveiling the roughly $2 billion stake his hedge fund, Third Point, recently took in the healthcare company.

05 Aug 2015

UPDATE 1-Loeb asks for board seats at Baxter, discloses new stake

BOSTON, Aug 5 - Billionaire investor Daniel Loeb on Wednesday asked for two board seats at Baxter International after publicly unveiling the roughly $2 billion stake his hedge fund, Third Point, recently took in the healthcare company.

05 Aug 2015

Loeb asks for board seats at Baxter, discloses new stake

BOSTON, Aug 5 - Billionaire investor Daniel Loeb on Wednesday asked for two board seats at Baxter International after publicly unveiling the roughly $2 billion stake his hedge fund, Third Point, recently took in the healthcare company.

05 Aug 2015

Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta

LONDON - Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases.

04 Aug 2015

UPDATE 5-Drugmaker Shire bids $30 bln for Baxter spin-off Baxalta

* Goes public with all-share offer after private approach rebuffed

04 Aug 2015

Deals of the day- Mergers and acquisitions

Aug 4 - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:

04 Aug 2015

BRIEF-Co Don presents results of Phase 2 trial in Chicago

* Announces presentation of the results of the Phase 2 trial in Chicago

03 Jun 2015

Fitch Downgrades Baxter International Inc. to 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, May 29 (Fitch) Fitch Ratings has downgraded Baxter International Inc.'s (Baxter) long-term Issuer Default Rating (IDR) by two notches to 'BBB+' and assigned a Stable Rating Outlook. In addition, Fitch downgraded the company's short-term IDR to 'F2' from 'F1'. Baxter had approximately $10 billion in outstanding debt at March 31, 2015. A full list of Fitch's ratings actions follows at the end of this release. KEY RATING DRIVE

29 May 2015

Novo Nordisk, Baxter clash over haemophilia drug patent

- Novo Nordisk on Wednesday rejected claims by Baxter International that its drug used substances developed by the U.S. rival, following the launch this week of a U.S. investigation into possible patent infringement.

20 May 2015

Novo Nordisk, Baxter clash over hemophilia drug patent

COPENHAGEN - Novo Nordisk on Wednesday rejected claims by Baxter International that its drug used substances developed by the U.S. rival, following the launch this week of a U.S. investigation into possible patent infringement.

20 May 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$49.00
Provider : Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks